CPNM Inicial
Portada » CPNM Inicial
- LINC
- NADIM
- NADIM II
- NADIM-ADJUVANT
LINC
LINC
(BR.31)
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer.
NADIM
NADIM
(GECP 16/03)
Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients
NADIM II
NADIM II
(GECP 18/02)
A Randomized Phase II Study of Neo-adjuvant Chemo/Immunotherapy Versus Chemotherapy Alone for the Treatment of Locally Advanced and Potentially Resectable Non-small Cell Lung Cancer (NSCLC) Patients.
NADIM-ADJUVANT
NADIM-ADJUVANT
(GECP 20/05)
A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.
